135 related articles for article (PubMed ID: 23951695)
1. Salivary concentration of epidermal growth factor in adults with reflux laryngitis before and after treatment.
Eckley CA; Sardinha LR; Rizzo LV
Ann Otol Rhinol Laryngol; 2013 Jul; 122(7):440-4. PubMed ID: 23951695
[TBL] [Abstract][Full Text] [Related]
2. Salivary epidermal growth factor concentration in adults with reflux laryngitis.
Eckley CA; Michelsohn N; Rizzo LV; Tadokoro CE; Costa HO
Otolaryngol Head Neck Surg; 2004 Oct; 131(4):401-6. PubMed ID: 15467608
[TBL] [Abstract][Full Text] [Related]
3. Salivary egf concentration in adults with reflux chronic laryngitis before and after treatment: preliminary results.
Eckley CA; Rios Lda S; Rizzo LV
Braz J Otorhinolaryngol; 2007; 73(2):156-60. PubMed ID: 17589721
[TBL] [Abstract][Full Text] [Related]
4. Salivary epidermal growth factor concentrations in patients with Sjögren syndrome and laryngopharyngeal reflux.
Eckley CA; Dos Anjos Corvo MA; Sardinha LR; Liquidato B; Rizzo LV
Ear Nose Throat J; 2017 Jun; 96(6):E6-E11. PubMed ID: 28636735
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of salivary pH and volume in adults with chronic laryngopharyngitis by gastroesophageal reflux disease before and after treatment.
Eckley CA; Costa HO
Braz J Otorhinolaryngol; 2006; 72(1):55-60. PubMed ID: 16917554
[TBL] [Abstract][Full Text] [Related]
6. Predictors of acid suppression success in patients with chronic laryngitis.
Wang AJ; Liang MJ; Jiang AY; Lin JK; Xiao YL; Peng S; Chen J; Wen WP; Chen MH
Neurogastroenterol Motil; 2012 May; 24(5):432-7, e210. PubMed ID: 22276941
[TBL] [Abstract][Full Text] [Related]
7. Medical therapy of reflux laryngitis.
Johnson DA
J Clin Gastroenterol; 2008; 42(5):589-93. PubMed ID: 18427287
[TBL] [Abstract][Full Text] [Related]
8. Gene expression changes of inflammatory mediators in posterior laryngitis due to laryngopharyngeal reflux and evolution with PPI treatment: a preliminary study.
Thibeault SL; Smith ME; Peterson K; Ylitalo-Moller R
Laryngoscope; 2007 Nov; 117(11):2050-6. PubMed ID: 17721405
[TBL] [Abstract][Full Text] [Related]
9. Salivary transforming growth factor alpha in patients with Sjögren's syndrome and reflux laryngitis.
Corvo MA; Eckley CA; Rizzo LV; Sardinha LR; Rodriguez TN; Bussoloti Filho I
Braz J Otorhinolaryngol; 2014; 80(6):462-9. PubMed ID: 25457064
[TBL] [Abstract][Full Text] [Related]
10. Comparison of patients of chronic laryngitis with and without troublesome reflux symptoms.
Wang AJ; Liang MJ; Jiang AY; Lin JK; Xiao YL; Peng S; Chen J; Wen WP; Chen MH
J Gastroenterol Hepatol; 2012 Mar; 27(3):579-85. PubMed ID: 21793907
[TBL] [Abstract][Full Text] [Related]
11. Detecting laryngopharyngeal reflux in patients with upper airways symptoms: Symptoms, signs or salivary pepsin?
Spyridoulias A; Lillie S; Vyas A; Fowler SJ
Respir Med; 2015 Aug; 109(8):963-9. PubMed ID: 26044812
[TBL] [Abstract][Full Text] [Related]
12. Impact of bile acids on the severity of laryngo-pharyngeal reflux.
De Corso E; Baroni S; Salonna G; Marchese M; Graziadio M; Di Cintio G; Paludetti G; Costamagna G; Galli J
Clin Otolaryngol; 2021 Jan; 46(1):189-195. PubMed ID: 32876387
[TBL] [Abstract][Full Text] [Related]
13. Saliva Pepsin Detection and Proton Pump Inhibitor Response in Suspected Laryngopharyngeal Reflux.
Wang CP; Wang CC; Lien HC; Lin WJ; Wu SH; Liang KL; Liu SA
Laryngoscope; 2019 Mar; 129(3):709-714. PubMed ID: 30247754
[TBL] [Abstract][Full Text] [Related]
14. Influence of age on treatment with proton pump inhibitors in patients with laryngopharyngeal reflux disease: a prospective multicenter study.
Lee YC; Lee JS; Kim SW; Kwon KH; Eun YG
JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1291-5. PubMed ID: 24201320
[TBL] [Abstract][Full Text] [Related]
15. Saliva Pepsin Concentration of Laryngopharyngeal Reflux Patients Is Influenced by Meals Consumed Before the Samples.
Lechien JR; Bobin F; Muls V; Horoi M; Thill MP; Dequanter D; Finck C; Rodriguez A; Saussez S
Laryngoscope; 2021 Feb; 131(2):350-359. PubMed ID: 32510588
[TBL] [Abstract][Full Text] [Related]
16. Gastro-oesophageal reflux disease in chronic laryngitis: prevalence and response to acid-suppressive therapy.
Qua CS; Wong CH; Gopala K; Goh KL
Aliment Pharmacol Ther; 2007 Feb; 25(3):287-95. PubMed ID: 17269990
[TBL] [Abstract][Full Text] [Related]
17. Evaluation and management of laryngopharyngeal reflux.
Ford CN
JAMA; 2005 Sep; 294(12):1534-40. PubMed ID: 16189367
[TBL] [Abstract][Full Text] [Related]
18. Expression of claudin-3 in the esophagus and larynx of rat reflux model.
Xu XB; Hu Y; Wang Y; Lai CJ; Zhang TY
Auris Nasus Larynx; 2014 Dec; 41(6):539-42. PubMed ID: 24928064
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of anti-reflux surgery on refractory laryngopharyngeal reflux disease in professional voice users: a pilot study.
Weber B; Portnoy JE; Castellanos A; Hawkshaw MJ; Lurie D; Katz PO; Sataloff RT
J Voice; 2014 Jul; 28(4):492-500. PubMed ID: 24629640
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of super high dose proton pump inhibitor administration in refractory laryngopharyngeal reflux: a pilot study.
Portnoy JE; Gregory ND; Cerulli CE; Hawkshaw MJ; Lurie D; Katz PO; Sataloff RT
J Voice; 2014 May; 28(3):369-77. PubMed ID: 24495427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
